BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15646057)

  • 1. Fungemia in acute leukemia patients: a single institution's experience.
    Specchia G; Pastore D; Montagna MT; Carluccio P; Ciuffreda L; Rizzi R; Liso A
    New Microbiol; 2004 Oct; 27(4):407-10. PubMed ID: 15646057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
    Nace HL; Horn D; Neofytos D
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
    Al-Tawfiq JA
    Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-species candidemia in patients with cancer.
    Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
    Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
    Safdar A; Bannister TW; Safdar Z
    Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungemia in non-HIV-infected patients: a five-year review.
    Anunnatsiri S; Chetchotisakd P; Mootsikapun P
    Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-onset candidemia at a university hospital, 1995-2005.
    Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
    J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Candida tropicalis fungemia in patients with cancer.
    Kontoyiannis DP; Vaziri I; Hanna HA; Boktour M; Thornby J; Hachem R; Bodey GP; Raad II
    Clin Infect Dis; 2001 Nov; 33(10):1676-81. PubMed ID: 11568858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed fungemia: incidence, risk factors, and mortality in a general hospital.
    Jensen J; Muñoz P; Guinea J; Rodríguez-Créixems M; Peláez T; Bouza E
    Clin Infect Dis; 2007 Jun; 44(12):e109-14. PubMed ID: 17516389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.
    Dutta A; Palazzi DL
    Pediatr Infect Dis J; 2011 Aug; 30(8):664-8. PubMed ID: 21372750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
    Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
    Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
    CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of candidemia at a Children's hospital, 2002 to 2006.
    Neu N; Malik M; Lunding A; Whittier S; Alba L; Kubin C; Saiman L
    Pediatr Infect Dis J; 2009 Sep; 28(9):806-9. PubMed ID: 19636286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata.
    Blot S; Vandewoude K; Hoste E; Poelaert J; Colardyn F
    J Hosp Infect; 2001 Apr; 47(4):308-13. PubMed ID: 11289775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.